[Sleep induction].
Physiological sleep induction is a fragile phenomenon which may be altered by environmental factors and various somatic and psychiatric disorders. Therefore sleep induction disorder is a common component of different types of insomnia, including sleep-onset insomnia and to a lesser degree multiple awakenings insomnia and early morning awakening insomnia. The treatment of sleep induction disorders is difficult and requires a precise analysis of the disorder and its aetiological factors. Specific treatment of aetiological factors is more likely to be efficacious in the long term than pharmacological sleep induction (eg: psychiatric disorders, sleep apnea syndrome, restless leg syndrome, periodic movements in sleep, disorders of the sleep-wake schedule...) when the use of hypnotic drugs is necessary agents not altering sleep architecture are preferred. Non-pharmacological methods could be used to induce sleep because they provide a better long term efficacy: sleep hygiene, relaxation techniques, biofeedback technique, psychotherapeutic techniques. Recently, some authors stress the use of treatment by restriction of time in bed and stimulus control treatment.
Unité des Troubles du Sommeil, Centre Gui de Chauliac, CHU, Montpellier.
J
J
Touchon
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001569:Benzodiazepines; D001676:Biofeedback, Psychology; D006801:Humans; D006920:Hygiene; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008019:Life Style; D011613:Psychotherapy; D012064:Relaxation Therapy; D012890:Sleep / Q000502:physiology; D012892:Sleep Deprivation; D007319:Sleep Initiation and Maintenance Disorders / Q000503:physiopathology / Q000523:psychology / Q000628:therapy*; D012893:Sleep Wake Disorders / Q000628:therapy
D014151:Anti-Anxiety Agents; D006993:Hypnotics and Sedatives; D001569:Benzodiazepines
Induction du sommeil.